GGrantIndex
← Leaderboards

Jennifer K. Lodge

Duke University

Google Scholar ↗PubMed ↗ORCID ↗
$14,326,240
Attributed
$20,060,259
Total exposure
10
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$20,060,259 · 10

By mechanism

R01$19,057,249 · 6
R56$396,500 · 1
K02$383,080 · 1
R29$216,430 · 1
R13$7,000 · 1

Top collaborators

Most similar at Duke University

Same institution · by research overlap

Others in their field

Top investigators on “Cryptococcus Neoformans”

Research focus

Cryptococcus NeoformansVirulenceCell WallResponseCellsMutantImmunocompromised HostProteinsAntifungal TherapyAntifungal AgentsCryptococcusGenesAcquired Immunodeficiency SyndromeAnabolismMycosesChitosanInfectionFundingChemotherapyMediatingDefectOrgan TransplantationFungusPatient Population

Grant awards (53)

Preclinical studies of a Cryptococcus vaccine for AIDS patients$769,284
R01 · FY2025 · AI · contact PI
Preclinical studies of a Cryptococcus vaccine for AIDS patients$793,078
R01 · FY2024 · AI · contact PI
Preclinical studies of a Cryptococcus vaccine for AIDS patients$793,078
R01 · FY2023 · AI · contact PI
Preclinical studies of a Cryptococcus vaccine for AIDS patients$753,820
R01 · FY2022 · AI · contact PI
Preclinical studies of a Cryptococcus vaccine for AIDS patients$799,003
R01 · FY2021 · AI · contact PI
ROLE OF CELL WALL INTEGRITY IN ECHINOCANDIN RESISTANCE IN C. NEOFORMANS$363,050
R01 · FY2021 · AI · contact PI
ROLE OF CELL WALL INTEGRITY IN ECHINOCANDIN RESISTANCE IN C. NEOFORMANS$47,706
R01 · FY2021 · AI · contact PI
Preclinical studies of a Cryptococcus vaccine for AIDS patients$644,346
R01 · FY2020 · AI · contact PI
ROLE OF CELL WALL INTEGRITY IN ECHINOCANDIN RESISTANCE IN C. NEOFORMANS$380,000
R01 · FY2020 · AI · contact PI
Preclinical studies of a Cryptococcus vaccine for AIDS patients$644,346
R01 · FY2019 · AI · contact PI
ROLE OF CELL WALL INTEGRITY IN ECHINOCANDIN RESISTANCE IN C. NEOFORMANS$380,000
R01 · FY2019 · AI · contact PI
Preclinical studies of a Cryptococcus vaccine for AIDS patients$644,346
R01 · FY2018 · AI · contact PI
Chitosan in Cryptococcus$412,445
R01 · FY2018 · AI · contact PI
ROLE OF CELL WALL INTEGRITY IN ECHINOCANDIN RESISTANCE IN C. NEOFORMANS$380,000
R01 · FY2018 · AI · contact PI
Preclinical studies of a Cryptococcus vaccine for AIDS patients$644,346
R01 · FY2017 · AI · contact PI
Chitosan in Cryptococcus$412,445
R01 · FY2017 · AI · contact PI
ROLE OF CELL WALL INTEGRITY IN ECHINOCANDIN RESISTANCE IN C. NEOFORMANS$393,125
R01 · FY2017 · AI · contact PI
Preclinical studies of a Cryptococcus vaccine for AIDS patients$657,471
R01 · FY2016 · AI · contact PI
Chitosan in Cryptococcus$415,291
R01 · FY2016 · AI · contact PI
Chitosan in Cryptococcus$417,585
R01 · FY2015 · AI · contact PI
Chitosan in Cryptococcus$430,559
R01 · FY2014 · AI · contact PI
2014 Cellular and Molecular Fungal Biology Gordon Research Conference$7,000
R13 · FY2014 · AI · contact PI
A NOVEL SCREEN FOR ANTIFUNGALS THAT TARGET CHITOSAN BIOSYNTHESIS$396,500
R56 · FY2012 · AI · contact PI
Signal transduction in C. neoformans$364,278
R01 · FY2012 · AI · contact PI
Signal transduction in C. neoformans$364,622
R01 · FY2011 · AI · contact PI
Chitosan in Cryptococcus$340,340
R01 · FY2011 · AI · contact PI
Signal transduction in C. neoformans$374,266
R01 · FY2010 · AI · contact PI
Oxidative and nitrosative stress resistance of Cryptococcus neoformans$368,980
R01 · FY2010 · HL · contact PI
Chitosan in Cryptococcus$343,778
R01 · FY2010 · AI · contact PI
Signal transduction in C. neoformans$387,735
R01 · FY2009 · AI · contact PI
Oxidative and nitrosative stress resistance of Cryptococcus neoformans$368,980
R01 · FY2009 · HL · contact PI
Chitosan in Cryptococcus$247,848
R01 · FY2009 · AI · contact PI
Chitosan in Cryptococcus$109,266
R01 · FY2009 · AI · contact PI
Oxidative and nitrosative stress resistance of Cryptococcus neoformans$356,843
R01 · FY2008 · HL · contact PI
Chitosan in Cryptococcus$350,250
R01 · FY2008 · AI · contact PI
Signal transduction in C. neoformans$235,769
R01 · FY2008 · AI · contact PI
Signal transduction in C. neoformans$140,904
R01 · FY2008 · AI · contact PI
Oxidative and nitrosative stress resistance of Cryptococcus neoformans$356,843
R01 · FY2007 · HL · contact PI
Oxidative/nitrosative stress resistance of Cryptococcus$367,500
R01 · FY2006 · HL · contact PI
Functional genomics of C.neoformans pathogenesis$358,864
R01 · FY2006 · AI · contact PI
Functional genomics of C.neoformans pathogenesis$367,500
R01 · FY2005 · AI
Identification of Antifungal Targets Using Proteomics$324,354
R01 · FY2005 · AI
Functional genomics of C.neoformans pathogenesis$367,500
R01 · FY2004 · AI
Identification of Antifungal Targets Using Proteomics$324,354
R01 · FY2004 · AI
Functional genomics of C.neoformans pathogenesis$367,500
R01 · FY2003 · AI
Identification of Antifungal Targets Using Proteomics$325,318
R01 · FY2003 · AI
GENETIC SCREEN FOR VIRULENCE GENES IN C NEOFORMANS$101,250
K02 · FY2003 · AI
Functional genomics of C.neoformans pathogenesis$368,333
R01 · FY2002 · AI
GENETIC SCREEN FOR VIRULENCE GENES IN C NEOFORMANS$101,250
K02 · FY2002 · AI
IDENTIFICATION--CRYPTOCOCCUS NEOFORMANS VIRULENCE GENES$109,812
R29 · FY2001 · AI
GENETIC SCREEN FOR VIRULENCE GENES IN C NEOFORMANS$97,322
K02 · FY2001 · AI
IDENTIFICATION--CRYPTOCOCCUS NEOFORMANS VIRULENCE GENES$106,618
R29 · FY2000 · AI
GENETIC SCREEN FOR VIRULENCE GENES IN C NEOFORMANS$83,258
K02 · FY2000 · AI